SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022

20.09.2022 - BOSTON and GENEVA, Switzerland, Sept. 20, 2022 (GLOBE NEWSWIRE) - SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, will host its first-ever Investor Day TODAY in-person at PUBLIC Hotel in New York City. The ...

Related Keywords

Ross Muken ,Jurgi Camblong ,Zhenyu Xu ,Ken Freedman ,Abhi Verma ,Peter Casasanto ,Troy Cox ,Instagram ,Exchange Commission ,Research Use ,Linkedin ,Twitter ,Facebook ,Nasdaq ,Chief Executive Officer ,Chief Revenue Officer ,Chief Biopharma Officer ,Philippe Menu ,Chief Medical Officer ,Chief Technology Officer ,Chief Scientific Officer ,Chief Financial Officer ,Investor Day ,Investor Relations ,Research Use Only ,Looking Statements ,